Hormones

Testosterone Myths Debunked: What Science Actually Says

Separating fact from fiction about the most misunderstood hormone

Testosterone is surrounded by myths — from the belief that it causes rage and prostate cancer to the idea that TRT is only for bodybuilders. Here's what the Endocrine Society guidelines and peer-reviewed research actually show.

Few hormones are as misunderstood as testosterone. Media portrayals associate it with aggression and steroid abuse, while medical conservatism has led to widespread under-diagnosis and under-treatment of genuine testosterone deficiency. The result: millions of men suffering from treatable symptoms while being told their levels are 'normal.'

The Endocrine Society, the American Urological Association, and large-scale clinical trials have established clear evidence on testosterone's role in health — evidence that contradicts many popular beliefs.

Myth vs. Fact

Myth: Testosterone causes aggressive behavior.
Fact: The relationship is far more nuanced than the 'roid rage' stereotype. A 2019 meta-analysis in Psychoneuroendocrinology found that testosterone is associated with status-seeking behavior (which can be cooperative or competitive) rather than aggression per se. TRT in hypogonadal men typically improves mood and reduces irritability — not increases aggression. Supraphysiological doses (as in anabolic steroid abuse) are a different matter.

Myth: Testosterone replacement therapy causes prostate cancer.
Fact: The 2018 Endocrine Society guidelines state there is no convincing evidence that TRT increases prostate cancer risk. The TRAVERSE trial (2023), the largest randomized TRT safety trial with 5,246 men, found no increased incidence of prostate cancer. The original fear came from a 1941 case report and has not been supported by subsequent large-scale studies.

Myth: Normal testosterone range means you're fine.
Fact: The standard reference range (264-916 ng/dL in many labs) includes the bottom 2.5th percentile — levels at which most men have significant symptoms. A 35-year-old at 280 ng/dL is 'in range' but likely symptomatic. Free testosterone and SHBG must also be evaluated; total T can be normal while free T is low.

More Common Myths

Myth: TRT always causes infertility.
Fact: Exogenous testosterone does suppress spermatogenesis by inhibiting FSH and LH. However, this is generally reversible within 6-12 months of discontinuation. Alternatives like clomiphene citrate and hCG can raise testosterone while preserving fertility. Men desiring future fertility should discuss these options before starting TRT.

Myth: Young men can't have low testosterone.
Fact: While less common than in older men, low testosterone in men under 30 is well-documented — caused by obesity, chronic stress, sleep deprivation, opioid use, pituitary disorders, or genetic conditions. The secular decline in population testosterone means today's young men have lower levels than previous generations at the same age.

Myth: Testosterone therapy is just for bodybuilders.
Fact: Clinical TRT restores levels to the normal physiological range (500-900 ng/dL), not the supraphysiological levels used in bodybuilding (often 1,500-5,000+ ng/dL). Clinical TRT is a medical treatment for a diagnosed deficiency, prescribed by endocrinologists and urologists with regular monitoring.

Myth: High testosterone makes you bald.
Fact: Male pattern baldness is driven by DHT (dihydrotestosterone) sensitivity at the hair follicle, which is genetically determined. Many men with high testosterone have full heads of hair, while men with low testosterone can experience significant hair loss. The relationship is with DHT receptor sensitivity, not testosterone level itself.

Frequently Asked Questions

Does testosterone replacement therapy cause heart attacks?

The TRAVERSE trial (2023) — a randomized, placebo-controlled trial in 5,246 men — found no increased cardiovascular risk with TRT over a median 33 months of follow-up. Earlier observational studies that raised this concern had significant methodological limitations. The Endocrine Society's 2018 guidelines state that TRT does not appear to increase cardiovascular risk in appropriately selected patients.

Is TRT a lifelong commitment?

Not necessarily. TRT for secondary hypogonadism caused by obesity, stress, or medications may be temporary — once the underlying cause is addressed, endogenous production may recover. However, some men (especially those with primary hypogonadism) will need long-term treatment. Clomiphene citrate is an alternative that stimulates natural production without suppressing the HPG axis.

Can women take testosterone?

Yes. Low-dose testosterone therapy is increasingly prescribed for postmenopausal women with hypoactive sexual desire disorder (HSDD). The 2019 Global Consensus Position Statement on Testosterone Therapy for Women supports testosterone therapy for HSDD, with evidence of efficacy from multiple RCTs. Typical female doses are 1/10th to 1/20th of male replacement doses.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health regimen.

Check Where You Stand

Take our free health assessment to understand your metabolic, hormonal, and recovery risk factors — and get personalized recommendations.

Take the Free Assessment →

Free · Takes 5 minutes · Instant results

Find out where you stand Free Assessment →

Continue Reading

← Back to Hormone Optimization

Understand your health — on your terms

Use our free tools and evidence-based guides to make smarter decisions about your metabolism, hormones, and recovery.

Take the Free Assessment →